期刊文献+

深圳居民甲型H1N1流感抗体水平影响因素的研究 被引量:2

Study on the factors affecting the levels of antibodies against the pandemic 2009 influenza A (H1N1) virus among residents in Shenzhen
原文传递
导出
摘要 目的 通过检测深圳居民血清中甲型H1N1流感抗体水平,了解相关的影响因素,为有效预防和控制甲型H1N1流感疫情提供有效科学依据. 方法 随机选取480位深圳居民作为观察对象,采用血凝抑制方法进行甲型H1N1流感抗体水平检测.并进行问卷调查,用SPSS16.0软件对血清抗体水平与不同流行病学指标之间进行相关因素分析. 结果 通过研究发现,年龄和甲流疫苗接种史与血清中甲型H1N1流感抗体水平显著性相关.6~15岁人群与已接种甲流疫苗人群血清中的甲型H1N1流感抗体阳性率显著性高于其它人群,阳性率分别是34.1%和48.1%.所有调查对象中,甲型H1N1流感疫苗接种率较低,仅为11.25%,6~15岁人群的疫苗接种率最高,为41.76%. 结论 青少年为甲型H1N1流感高危人群,加强对该人群的免疫接种,可对甲型H1N1流感的疫情控制起到显著成效. Objective To investigate the seroprevalence of antibodies against the pandemic 2009 influenza A (H1N1) virus [A (H1N1)pdm09] among residents in Shenzhen and to identify the related influencing factors so as to provide scientific evidence for effective prevention and control of the disease.Methods We randomly selected 480 residents in Shenzhen in 2010 to serve as the survey subjects,and their levels of antibodies against the pandemic 2009 influenza A (H1N1) virus were tested by haemagglutination inhibition assays.Self-reported vaccination histories and socio-demographic information were also collected by questionnaires.SPSS16.0 software was used to analyze the association between seroprevalence and social-demographic factors.Results Age and vaccine exposure were significantly correlated with the seroprevalence of antibodies against the pandemic 2009 influenza A (H1N1) virus.The seropositive rate for A (H1N1) pdm09 antibodies was significantly higher in teenagers aged between 6 and 15 years (34.1%) and people previously vaccinated with pandemic vaccine (48.1%) than in other people.Among the subjects investigated,the total rate of vaccination for H1N1 was low (only 11.25%),while that of age group 6-15 years was high (41.76%).Conclusions Children and teenagers are at high risk of catching H1N1 influenza infection,and hence,reinforcing the vaccination among them would be significantly effective to control the epidemic of the disease.
出处 《实用预防医学》 CAS 2014年第8期932-934,共3页 Practical Preventive Medicine
关键词 深圳 甲型H1N1流感 抗体水平 影响因素 Shenzhen The pandemic 2009 influenza A (H1N1) Antibody lcvel Influencing factors
  • 相关文献

参考文献8

  • 1Dawood FS,Jain S,Finelli L,et al.Emergence of a novel swine-origin influenza A (H1N1) virus in humans[J].N Engl J Med,2009,360(25):2605-2615.
  • 2World health Organization.Pandemic (H1N1) 2009 up date 90[R/OL].Geneva,WHO[2010-03-05].Http:/www.who.int/csr/don/2010-03 05/en/index.html.
  • 3赵超敏,陈斌,周伴群,吴水滨,焦亮,罗志华.珠海市斗门区人群甲型H1N1流感病毒抗体影响因素分析[J].实用预防医学,2011,18(12):2294-2296. 被引量:1
  • 4汤奋扬,嵇红,祁贤,李亮,祖荣强,霍翔,许可,朱凤才,孟繁岳.江苏省2009年甲型H1N1流感流行病学及病原学特征分析[J].江苏预防医学,2010,21(1):1-4. 被引量:22
  • 5Wu JT,Ma ES,Lee CK,et al.The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong[J].Clin Infect Dis,2010,51(10):1184-1191.
  • 6Miller E,Hoschler K,Hardelid P,et al.Incidence of 2009 pandemic influenza A H1N1 infection in England:a cross-sectional serological study[J].Lancet,2010,375(9720):1100-1108.
  • 7Skowronski DM,Hottes TS,Janjua NZ,et al.Prevalence of seropro tection against the pandemic (H1N1) virus after the 2009 pandemic[J].CMAJ,2010,182(17):1851-1856.
  • 8Gilbert GL,Cretikos MA,Hueston L,et al.Influenza A (H1N1) 2009 antibodies in residents of New South Wales,Australia,after the first pandemic wave in the 2009 southern hemisphere winter[J].PLoS One,2010,5(9):e12562.

二级参考文献14

  • 1WHO. New influenza A ( H1N1 ) virus: global epidemiological situation[J]. Weekly epidemiological record, 2009, 84(25):249- 260.
  • 2Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans[J]. N Engl J Med, 2009, 360(25) :2 667-2 668.
  • 3Webster RG, Bean WJ, Gorman OT, et al. Evolution and ecology of influenza A viruses[J]. Microbiol Rev, 1992, 56(1): 152- 179.
  • 4Reid AH, Fanning TG, Hultin JV, et al, Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene[J]. Proc Natl Acad Sci USA, 1999, 96(4): 1 651-1 656.
  • 5Matrosovich M, Tuzikov A, Bovin N, et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals [J]. Virology, 2000, 74(18):8 502-8 512.
  • 6Fraser, C, C.A. Donnelly, S. Cauchemez, et al. Pandemic potential of a strain of influenza A (H1N1) : early findings[J].Science, 2009, 324(5934) : 1557 - 1561.
  • 7Dawood, F. S, S. Jain, L, Finelli, et al. Emergence of a novel swine -origin influenza A (H1N1) virus in humans[J]. N Engl J Med, 2009, 360(2.5) :2605 - 2615.
  • 8Tian, L. L, W.X. Shi, D. Ying, et al. SeroLogic survey of pandemic influenza A (H1N1 2009) in Beijing, China[J]. Prev Med, 2011, 52 (1):71-74.
  • 9Song, J.Y, H.J. Cheong, J.Y. Heo, et al. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea[J]. Vaccine, 2011, 29(7) : 1395 - 1398.
  • 10Choi, S. H, J.W. Chung, M. H, Jeon, et al. Risk factors for pandemic H1N1 2009 iniection in healthcare personnel of four general hospitals [J]. J Infect, 2011.

共引文献21

同被引文献12

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部